AF
TSVT

Amalgamated Financial’s 2seventy bio TSVT Stock Holding History

Amalgamated Financial’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$46K Buy
+2,722
New +$46.2K ﹤0.01% 2476

Other funds holding TSVT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Amalgamated Financial's TSVT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in 2seventy bio (TSVT) in Q1 2022: 2,722 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings.

134 funds tracked by Wall St. Rank hold TSVT as of Q1 2022.

  • Amalgamated Financial held 2,722 shares of 2seventy bio worth $46K as of Q1 2022.
  • 2seventy bio was a new Amalgamated Financial position in Q1 2022.
  • 2seventy bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2476 holding.
  • 134 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.